| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Invenomic Master Fund LP | Hedge | $494.4M | $1M |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Ali Nmn Motamed Control | Managing Partner | Over 75% | 2015 |
| Benjamin Robert Deschaine Control | President | Under 5% | 2019 |
| Invenomic GP LLC Control | General Partner | Under 5% | 2015 |
Invenomic Capital Management LP reports $3.2 billion in regulatory assets under management on its Form ADV.
Invenomic Capital Management LP manages 1 private funds with combined gross assets of $494.4 million.
Invenomic Capital Management LP reports 18 employees.
Invenomic Capital Management LP is based in Boston, MA and has been SEC-registered since 2017.
Invenomic Capital Management LP is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 211 Congress St, 8th Floor, Boston, MA 02110 |
| Phone | 617-729-2323 |
| Office hours | 9:00 a.m. To 5:00 p.m. |
| SEC region | Boston Regional Office (BRO) |
| CIK | 1769456 |
| Discloses disciplinary history | No |
| Discretionary | $3.21B |
| Non-discretionary | $0 |
| Total (RAUM) | $3.21B |